Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc.

Overview
Date Founded

2007

Headquarters

Oceanic Plaza,1066 West Hastings Street,Suite 2600,Vancouver, BC V6E 3X1

Type of Company

Public

Employees (Worldwide)

19

Industries

Pharmaceuticals

Company Description

Emerald Health Therapeutics, Inc. is a pharmaceutical company, which engages in the development and production of medical marijuana products. Its products include dried cannabis and cannabis oil. The company was founded on Jul 31, 2007 and is headquartered in Victoria, Canada.

Executives & Employees

Chief Executive Officer & Director

Chief Financial Officer

Chief Operating Officer of Emerald Health Therapeutics Canada

Vice President-Research

Vice President Finance

Vice President of Sales & Marketing

Vice President-Quality Affairs

Board of Directors

Chairman, President & Chief Executive Officer at Emerald Health Sciences, Inc.

Managing Director-Western Canada at Gold Medal Plates

Co-Founder at OncoSec Medical, Inc.

Chief Executive Officer & Director at Emerald Health Therapeutics, Inc.

Chief Executive Officer & Executive Director at Vanc Pharmaceuticals, Inc.

Paths to Emerald Health Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Emerald Health Therapeutics, Inc.
Owners & Shareholders
Details Hidden

Penserra Capital Management specializes in transition management services and also offers an ETF sub-advisory service. The firm subscribes to the objectivity of statistical models in evaluating the risk and exposure associated with the restructuring of transition portfolios, as well as the construction and maintenance of ETFs. They believe the key to producing a successful portfolio outcome for transition management is capital preservation and for ETF management is low tracking error relative to the benchmark. As such, Penserra analyzes the attributes of the initial portfolio and benchmark portfolios to determine the most risk-averse method for restructuring the client's assets or tracking the benchmark. The firm measures the performance of client portfolios relative to an implementation shortfall benchmark for transition management and relative to tracking difference and tracking error for ETF management.

Details Hidden

Horizons ETFs Management (Canada) and their affiliate AlphaPro Management, Inc., offer the Horizons ETFs family of exchange traded funds. The Horizons ETFs family includes a broadly diversified range of investment tools with solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Their products include Alpha ETFs, Benchmark ETFs, and BetaPro ETFs.The Horizon Alpha ETFs are actively managed funds that cover a range of asset classes including Equity Income, Fixed Income, Covered Calls, Currencies, Alternatives, Multi-Asset.The Horizon Benchmark ETFs are indexing evolved funds which cover the following investment types: Equity, Alternatives, Currencies, Commodities, and Total Return Index. The BetaPro ETFs are designed to profit or protect in bull and bear markets. The Bull Plus ETFs include Leveraged Equities (2X), Leveraged Commodities (2X), Leveraged Volatility (2X), and Non-Leveraged Volatility (1X). The Bear Plus ETFs include Inverse Leveraged Equities (-2X), Inverse Leveraged Commodities (-2X), Leveraged Fixed Income (-2X), Inverse Equities (-1X), and Inverse Volatility (-1X).

Details Hidden

Penserra Capital Management specializes in transition management services and also offers an ETF sub-advisory service. The firm subscribes to the objectivity of statistical models in evaluating the risk and exposure associated with the restructuring of transition portfolios, as well as the construction and maintenance of ETFs. They believe the key to producing a successful portfolio outcome for transition management is capital preservation and for ETF management is low tracking error relative to the benchmark. As such, Penserra analyzes the attributes of the initial portfolio and benchmark portfolios to determine the most risk-averse method for restructuring the client's assets or tracking the benchmark. The firm measures the performance of client portfolios relative to an implementation shortfall benchmark for transition management and relative to tracking difference and tracking error for ETF management.

Recent Transactions
Details Hidden

Emerald Health Therapeutics, Inc., Emerald Health Bioceuticals, Inc., Emerald Health Naturals purchase GAB Innovations Ltd.

Details Hidden

Emerald Health Therapeutics, Inc. purchases Northern Vine Canada, Inc. from Abattis Bioceuticals Corp.

Details Hidden

Emerald Health Therapeutics, Inc. issued Units

Transaction Advisors
Auditor

Advised onEmerald Health Therapeutics, Inc. issued Units

Underwriter

Advised onEmerald Health Therapeutics, Inc. issued Units

Legal Advisor

Advised onEmerald Health Therapeutics, Inc. issued Units

Advisors & Consultants
Advisor

Vice President, Investor Relations & Communications at Inovio Pharmaceuticals Inc.

Advisor

Former Head-Investor Relations at Columbus Gold Corp.

Advisor
Key Stats and Financials As of 2017
Market Capitalization
$344M
Total Enterprise Value
$418M
Earnings Per Share
$-0.1
Net Profit
$-8.73M
EBITDA
$-8.98M
EBITDAMargin
-957.52%
Total Debt
$0
Total Equity
$67.8M
Enterprise Value Sales
446.06x
TEVNet Income
-47.9x
Debt TEV
0x
Revenue
$938K
Five Year Compounded Annual Growth Rate Of Revenue
41.34%
Three Year Compounded Annual Growth Rate Of Revenue
105.48%
Investments
Details Hidden

iForce Group Ltd. provides tailored e-fulfillment solutions for both store and internet retailers. The firm’s specialties include logistics, returns processing, e-fulfilment, carriage management, returns recovery and supply chain. The company was founded in 1997 and is headquartered in Warrington, the United Kingdom.